Shareholding disclosure

Roche Finanz AG

Declared position

12.08%

Threshold

Crossed upwards

Timeline

Published

27.12.2007

Transaction

—

Voting rights breakdown

Voting rights acquired12.08%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T5464D5224

Beneficial owner

Roche Finanz AG

Declared address

Roche Finanz AG, Basel

Kontaktperson: Dr. Lukas Engelberger, Grenzacherstr. 124, 4058 Basel, +41 (0) 61 688 93 44

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Roche Finanz AG

Basilea Pharmaceutica AG, Allschwil27.12.2007T5464D5224

Disclosure summary

Roche Finanz AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 27.12.2007, at 12.08% of voting rights. Notice category: Group of shareholders.

Disclosed position

12.08%

Voting rights acquired

Voting rights acquired12.08%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Roche Finanz AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 27.12.2007.

Publication date27.12.2007

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerRoche Finanz AG

Declared addressRoche Finanz AG, Basel

CategoryGroup of shareholders

Voting rights acquired12.08%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT5464D5224

Commercial register

CHE-103.000.037

Registered

Zefix record

Conditions

Kontaktperson: Dr. Lukas Engelberger, Grenzacherstr. 124, 4058 Basel, +41 (0) 61 688 93 44

Source: SIX Exchange Regulation · Publication date: 27.12.2007

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open